(Q72697329)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6189492%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Anti-proliferative properties of Clozic, a disease-modifying anti-arthritic agent (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6189492%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Anti-proliferative properties of clozic, A disease-modifying anti-arthritic agent (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

24 August 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

24 August 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

24 August 2023

author name string

S. J. Foster

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6189492

24 August 2023

M. E. McCormick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6189492

24 August 2023

C. J. Cunliffe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6189492

24 August 2023

language of work or name

English

0 references

publication date

1 February 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6189492%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

https://api.elsevier.com/content/article/PII:0006295283905245?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

https://api.elsevier.com/content/article/PII:0006295283905245?httpAccept=text/plain

24 August 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

24 August 2023

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6189492%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6189492%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6189492%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

461-467

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6189492%20AND%20SRC:MED&resulttype=core&format=json

Effect of gold sodium thiomalate on proliferation of human rheumatoid synovial cells and on collagen synthesis in tissue culture

28 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

Changes in the growth and metabolism of cells cultured from normal, sclerotic and rheumatoid connective tissue brought about by D-penicillamine and by sodium salicylate

24 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

Rheumatoid arthritis: effects of a new agent (ICI 55 897) on serum acute phase proteins and the erythrocyte sedimentation rate

24 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

Evidence that prostaglandins do not have a role in the cytostatic action of anti-inflammatory drugs

24 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle

24 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

Cytostatic activity of pharmacological concentrations of indomethacin in cell cultures and inactivity of closely related compounds

24 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

Structure-action relationship among drugs acting on connective tissues (anti-rheumatic agents).

24 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

Ability of Some Antirheumatic Drugs to uncouple Oxidative Phosphorylation

24 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

Uncoupling of Oxidative Phosphorylation by some Arylacetic Acids (Anti-inflammatory or Hypocholesterolemic Drugs)

24 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

Protein binding of indomethacin: binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate, in vitro

24 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

The pharmacology of benoxaprofen (2-[4-chlorophenyl]-α-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with anti-inflammatory activity apparently unrelated to inhibition of prostaglandin synthesis

24 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

Effects of the non-steroidal anti-inflammatory drug benoxaprofen on leucocyte migration

24 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

Microelectrometric titration measurement of the pKa's and partition and drug distribution coefficients of narcotics and narcotic antagonists and their pH and temperature dependence

24 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0006-2952(83)90524-5

24 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6189492%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference